Strs Ohio Invests $190,000 in STAAR Surgical Company $STAA

Strs Ohio purchased a new stake in shares of STAAR Surgical Company (NASDAQ:STAA) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,800 shares of the medical instruments supplier’s stock, valued at approximately $190,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in STAA. US Bancorp DE grew its stake in STAAR Surgical by 1,693.0% in the first quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 1,930 shares during the last quarter. Brooklyn Investment Group grew its stake in STAAR Surgical by 1,564.0% in the first quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier’s stock valued at $47,000 after purchasing an additional 2,518 shares during the last quarter. EntryPoint Capital LLC purchased a new position in STAAR Surgical in the first quarter valued at about $189,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in STAAR Surgical by 29.6% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,076 shares of the medical instruments supplier’s stock valued at $248,000 after purchasing an additional 3,217 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in STAAR Surgical by 4,086.0% in the first quarter. GAMMA Investing LLC now owns 14,651 shares of the medical instruments supplier’s stock valued at $258,000 after purchasing an additional 14,301 shares during the last quarter. Hedge funds and other institutional investors own 96.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on STAA shares. Canaccord Genuity Group lifted their target price on STAAR Surgical from $20.00 to $28.00 and gave the stock a “hold” rating in a report on Wednesday, August 6th. Stifel Nicolaus set a $28.00 price target on STAAR Surgical and gave the company a “hold” rating in a report on Thursday, August 7th. Mizuho boosted their price target on STAAR Surgical from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Wednesday, July 16th. Finally, Piper Sandler raised STAAR Surgical to a “hold” rating in a report on Wednesday, June 18th. Ten analysts have rated the stock with a Hold rating, Based on data from MarketBeat, STAAR Surgical has an average rating of “Hold” and an average price target of $20.67.

STAAR Surgical Stock Up 0.8%

Shares of NASDAQ:STAA opened at $26.77 on Thursday. The business has a fifty day moving average of $25.13 and a two-hundred day moving average of $20.18. The stock has a market cap of $1.32 billion, a P/E ratio of -13.87 and a beta of 0.74. STAAR Surgical Company has a 52-week low of $13.50 and a 52-week high of $38.60.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.